Optimizing the Continuum of Care in Gastric Cancer

Optimizing the Continuum of Care in Gastric Cancer

Beatrice Riccò,&ast; Giulio Martinelli,&ast; Camilla Bardasi, Massimo Dominici, Andrea Spallanzani, Massimiliano Salati Department of Oncology and Hematology, University Hospital of Modena, Modena, Italy&ast;These authors contributed equally to this workCorrespondence: Andrea Spallanzani...

Full description

Bibliographic Details
Main Authors:	Riccò B, Martinelli G, Bardasi C, Dominici M, Spallanzani A, Salati M
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-11-01
Series:	OncoTargets and Therapy
Subjects:	gastric cancer gastroesophageal cancer continuum of care target therapies
Online Access:	https://www.dovepress.com/optimizing-the-continuum-of-care-in-gastric-cancer-peer-reviewed-fulltext-article-OTT

Similar Items

Molecular Targets for Gastric Cancer Treatment and Future Perspectives from a Clinical and Translational Point of View
by: Justus Körfer, et al.
Published: (2021-10-01)

Transcatheter arterial chemoembolization combined with apatinib and camrelizumab for unresectable advanced gastric or gastroesophageal junction cancer: a single-arm, single-center, retrospective study
by: Kunpeng Wu, et al.
Published: (2023-09-01)

New Treatment Options for Advanced Gastroesophageal Tumours: Mature for the Current Practice?
by: Hannah Christina Puhr, et al.
Published: (2020-01-01)

Targeting FGFR2 Positive Gastroesophageal Cancer: Current and Clinical Developments
by: Gordon A, et al.
Published: (2022-10-01)

Expression of Her2-Neu in Primary Gastric and Gastroesophageal Adenocarcinoma: An Experience from a Tertiary Center in South India
by: Aditi Damle, et al.

The Impact of Ramucirumab Treatment on Survival and Quality of Life in Patients with Gastric Cancer
by: Mehta R, et al.
Published: (2020-01-01)

Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer—Results from the AGMT GASTRIC-5 Registry
by: Florian Huemer, et al.
Published: (2020-03-01)

First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal junction cancer
by: Selin Aktürk Esen, et al.
Published: (2022-09-01)

Recent Developments of Systemic Chemotherapy for Gastric Cancer
by: Hiroyuki Arai, et al.
Published: (2020-04-01)

The impact of preoperative waiting time in Stage II–III gastric or gastroesophageal junction cancer: A population‐based cohort study
by: Chih‐Chieh Yen, et al.
Published: (2023-08-01)

A Clinical Viewpoint on the Use of Targeted Therapy in Advanced Gastric Cancer
by: Magdalena Skórzewska, et al.
Published: (2023-11-01)

The origin of gastric cancer stem cells and their effects on gastric cancer: Novel therapeutic targets for gastric cancer
by: Ying Yang, et al.
Published: (2022-09-01)

The need for continuum of care in control of hypertension in primary health-care setting
by: Immanuel Joshua, et al.
Published: (2023-01-01)

Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma
by: Massimiliano Salati, et al.
Published: (2022-09-01)

UICC Staging after Neoadjuvant/Perioperative Chemotherapy Reveals No Significant Survival Differences Compared to Primary Surgery for Locally Advanced Gastric Cancer
by: Rebekka Dimpel, et al.
Published: (2022-12-01)

Novel Biomarkers of Gastric Adenocarcinoma: Current Research and Future Perspectives
by: Nadja Niclauss, et al.
Published: (2021-11-01)

Preoperative treatment with radiochemotherapy for locally advanced gastroesophageal junction cancer and unresectable locally advanced gastric cancer
by: Ratosa Ivica, et al.
Published: (2015-06-01)

Research Status and Progress on Treatment of Advanced Gastric Cancer
by: DONG Caixia, et al.
Published: (2022-11-01)

Multiphasic Prehabilitation Across the Cancer Continuum: A Narrative Review and Conceptual Framework
by: Daniel Santa Mina, et al.
Published: (2021-01-01)

Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR)
by: Mélanie Dos Santos, et al.
Published: (2022-05-01)

Perspectives on the Management of Oligometastatic Disease in Esophago-Gastric Cancer
by: Thorsten Oliver Goetze, et al.
Published: (2022-10-01)

The integration of immune checkpoint inhibitors with VEGF targeted agents in advanced gastric and gastroesophageal adenocarcinoma: a review on the rationale and results of early phase trials
by: Anwaar Saeed, et al.
Published: (2021-01-01)

Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis
by: Yulia Kundel, et al.
Published: (2020-10-01)

Efficacy and safety of camrelizumab combined with oxaliplatin and S‐1 as neoadjuvant treatment in locally advanced gastric or gastroesophageal junction cancer: A phase II, single‐arm study
by: Wen‐Jin Zhong, et al.
Published: (2024-02-01)

Significance of Lauren Classification in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany
by: Rebekka Schirren, et al.
Published: (2021-01-01)

HER2-targeted advanced metastatic gastric/gastroesophageal junction adenocarcinoma: treatment landscape and future perspectives
by: Weiling Li, et al.
Published: (2022-09-01)

Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era
by: Maluki Radford, et al.
Published: (2023-08-01)

Case report of the rapid achievement of sustained and long-term remission resulting from the use of ramucirumab plus paclitaxel in the second-line treatment of a patient with disseminated gastric adenocarcinoma
by: T. A. Titova, et al.
Published: (2018-07-01)

Cervical Cancer Care Continuum in South India: Evidence from a Community-based Screening Program
by: E. Vidhubala, et al.
Published: (2019-11-01)

The Multidisciplinary Approach and Surgical Management of GE Junction Adenocarcinoma
by: Meher Oberoi, et al.
Published: (2024-01-01)

The care continuum with interprofessional oncology teams: Perspectives of patients and family
by: Karine Bilodeau, et al.
Published: (2015-01-01)

Gastric Cancer: Mechanisms, Biomarkers, and Therapeutic Approaches
by: Sangjoon Choi, et al.
Published: (2022-02-01)

Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial
by: Jodi V. Mones, et al.
Published: (2021-07-01)

Advances and Prospects of Nanotheranostic Technology for Gastric Cancer
by: Daxiang Cui, et al.
Published: (2016-12-01)

Gastric cancer treatment: recent progress and future perspectives
by: Wen-Long Guan, et al.
Published: (2023-05-01)

Perioperative treatment and biomarker analysis of LP002, an anti‐PD‐L1 antibody, plus chemotherapy in resectable gastric and gastroesophageal junction cancer
by: Jia‐lin Tang, et al.
Published: (2023-03-01)

Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?
by: Rilan Bai, et al.
Published: (2020-07-01)

Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial
by: Tianshu Liu, et al.
Published: (2019-06-01)

Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil
by: Xu Z, et al.
Published: (2019-05-01)

Advances of Targeted Therapy and Immune Checkpoint Therapy on Gastric Cancer
by: WANG Xin, et al.
Published: (2020-12-01)